Breast Cancer Research and Treatment

Effects of raloxifene on normal breast tissue from premenopausal women
pp. 99-103(5)
Authors: Silva, Benedito; Lopes, Ione; Gebrim, Luiz

Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland
pp. 105-109(5)
Authors: Gronwald, Jacek; Byrski, Tomasz; Huzarski, Tomasz; Cybulski, Cezary; Sun, Ping; Tulman, Anna; Narod, Steven; Lubinski, Jan

Accuracy and reliability of sentinel node biopsy in patients with breast cancer. Single centre study with long term follow-up
pp. 111-116(6)
Authors: Carcoforo, P.; Sortini, D.; Soliani, G.; Basaglia, E.; Feggi, L.; Liboni, A.

Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients
pp. 117-123(7)
Authors: Tilanus-Linthorst, Madeleine; Bartels, Karina; Alves, Celina; Bakri, Bonnie; Crepin, Ellen; Ouweland, Ans; Klijn, Jan; Meijers-Heijboer, Hanne; Brekelmans, Cecile

The (mis)classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy
pp. 125-129(5)
Authors: Shilling, Val; Jenkins, Valerie; Trapala, Ivonne

Antidepressant use and breast cancer risk
pp. 131-140(10)
Authors: Chien, Chloe; Li, Christopher; Heckbert, Susan; Malone, Kathleen; Boudreau, Denise; Daling, Janet

Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer
pp. 141-145(5)
Authors: Lener, Marcin Radosław; Oszutowska, Dorota; Castaneda, Jennifer; Kurzawski, Grzegorz; Suchy, Janina; Nej-Wołosiak, Katarzyna; Byrski, Tomasz; Huzarski, Tomasz; Gronwald, Jacek; Szymańska, Anna; Szymańska-Pasternak, Jolanta; Grodzki, Tomasz; Serwatowski, Piotr; Bre¸borowicz, Grzegorz; Scott, Rodney; Lubiński, Jan

Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case–control analysis
pp. 147-152(6)
Authors: Ruvalcaba-Limón, Eva; Robles-Vidal, Carlos; Poitevin-Chacón, Adela; Chávez-MacGregor, Mariana; Gamboa-Vignolle, Carlos; Vilar-Compte, Diana

Microsatellite profile in hormonal receptor genes associated with breast cancer
pp. 153-159(7)
Authors: Iobagiu, C.; Lambert, C.; Normand, M.; Genin, C.

Promoter methylation reduces C/EBPδ (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors
pp. 161-170(10)
Authors: Tang, D.; Sivko, G.S.; DeWille, J.W.

Pre-diagnosis physical activity and mammographic density in breast cancer survivors
pp. 171-178(8)
Authors: Irwin, Melinda; Aiello, Erin; McTiernan, Anne; Baumgartner, Richard; Baumgartner, Kathy; Bernstein, Leslie; Gilliland, Frank; Ballard-Barbash, Rachel

Different clinical impact of estradiol receptor determination according to the analytical method: a study on 1940 breast cancer patients over a period of 16 consecutive years
pp. 179-184(6)
Authors: Magné, N.; Toillon, R.-A.; Castadot, P.; Ramaioli, A.; Namer, M.

Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression
pp. 185-194(10)
Authors: Grillo, Mary; Bott, Matthew; Khandke, Neha; McGinnis, John; Miranda, Miriam; Meyyappan, Muthupalaniappan; Rosfjord, Edward; Rabindran, Sridhar

Acknowledgements
pp. 195-197(3)